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Genetics of kidney disease. Multiple lines of evidence suggest At this time we can presume with some confidence
that susceptibility to develop end-stage renal disease (ESRD) that individual risk of developing ESRD is a function of
has a significant genetic component. These studies include fa- not only inheritance, that is, genetic risk, but also themilial aggregation studies, comparisons of incidence rates be-
environment in which a person lives and the lifestyletween different racial or ethnic populations, and segregation
that a person leads. We envision that ESRD susceptibil-analysis. Multiple approaches have been employed in an effort
to identify genes that contribute to this genetic susceptibility. ity genes are not the “yes” or “no” genes of monogenic
Many studies have now been carried out assessing the contribu- disorders, but genes whose risk is modified by elements
tion of specific “candidate genes,” that is, genes with functions
such as diet, exercise, occupation, and, especially in renalconsistent with involvement in renal pathogenesis. Indepen-
disease the co-existence of diabetes or hypertension. Indent evaluations of specific candidate genes have frequently
provided contradictory results. This may be due, in part, to the the United States the most common co-existing medical
modest contribution to genetic susceptibility that these genes conditions are Type 1 diabetes (T1DM), Type 2 diabetes
impart. In contrast to the focused analysis of candidate genes, (T2DM), and hypertension. Thus, lifestyle and environ-the genome scan approach employs a comprehensive evalua-
ment can contribute to increased or decreased risk fortion of inheritance throughout the genome. The great potential
renal disease.advantage of the genome scan is the ability to identify chromo-
somal regions harboring novel, previously unrecognized, genes
that contribute to renal disease. Results from whole genome
scans of family collections are now beginning to appear and give EVIDENCE FOR A GENETIC COMPONENT TO
the promise that multiple comprehensive genetic evaluations of RENAL DISEASE
end-stage renal disease will soon be available for evaluation.
There is now extensive evidence from a wide variety
of approaches that suggests renal disease in the general
population has a genetic component. The most numerousThe purpose of this article is to present an overview
studies take the form of evaluating familial aggregation.of current thinking and ongoing research in genetic stud-
In their simplest form, familial aggregation studies evalu-ies of renal disease. Emphasis has been placed on current
ate the incidence of renal disease in families with indexefforts to identify the genetic components of common
cases with renal disease compared to the incidence offorms of renal disease. It is now widely accepted that
renal disease in families with index cases without renalthe genes an individual inherits from their parents con-
disease. Seaquist et al published the first description oftribute to susceptibility to inherit many forms of renal
familial aggregation in renal disease, primarily studyingdisease. All of us are familiar with the clearly genetic
Caucasian Type 1 diabetes families (T1DM) [1]. Familiesforms of kidney disease such as polycystic kidney disease,
containing individuals who had undergone kidney trans-Alport syndrome, some forms of focal segmental glomer-
plantation were compared to families who contained dia-ular sclerosis and IgA nephropathy. From the pattern
betes-affected individuals without substantial renal dis-of inheritance it is clear that such medical conditions are
ease. While 17% of the diabetic siblings of the probandscaused by single genes, and in several cases these genes
without nephropathy had renal disease as judged by cre-have now been identified. Although these disorders have
atinine clearance and a urinary albumin excretion rate,devastating impact on affected individuals and their fam-
ilies, the monogenic forms of kidney disease comprise a 83% of diabetic siblings of probands receiving kidney
relatively small percentage of the total number of people transplants had renal involvement (P 0.001). An inter-
with ESRD. esting observation is that the two groups did not differ
in their glycemic control. Similar results were reported
by Borch-Johnsen et al in a European study of T1DMKey words: inherited kidney disease, heritable renal disease, genome
screening, familial genetic evaluation, candidate genes. families [2] and American T1DM families [3]: nephropa-
thy clustered in families, but there was no significant 2003 by the International Society of Nephrology
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ent lifestyles and diets that would contribute to differen-
tial selection of genetic alleles in the different popula-
tions. This different genetic heritage should be reflected,
in the case of renal disease, in different rates of renal
disease in different populations. One alternative expla-
nation put forth to explain these disparities is that racial
or ethnic minorities have lower economic status and con-
sequently more limited access to medical care. While
this may explain some of the differences, several studies
have controlled for socioeconomic status and still ob-
served significant differences between rates of renal com-
plications when comparing American Caucasians and
Fig. 1. Familial clustering of diabetes associated kidney disease. Com- African American patients [6, 7, 9, 13]. As summarized
parison of frequency of renal disease in siblings or relative of diabetes- earlier, Freedman and colleagues have introduced a new
affected individuals with ESRD (bars on the left) compared to the
perspective on studies of racial/ethnic differences by in-frequency of renal disease in siblings or relative of diabetes-affected
individuals without renal involvement (bars on the right). Bars represent corporating a familial aggregation analysis into their com-
data from analysis of: Caucasian T1DM subjects, Seaquist et al [1] parisons of racial groups [6, 7, 9], observing that family
labeled “S”; Caucasian type 1 diabetes mellitus (T1DM) subjects, Quinn
clustering was more pronounced in African Americanset al [3] labeled “K”, and African American T2DM subjects, Freedman
et al [6] labeled “F”. than in Caucasians.
Finally, one of the most challenging approaches, segre-
gation analysis, has been used by two groups to evaluate
genetic components of diabetes complications [14, 15].
difference between measures of glycemic control be- Fogarty et al studied 96 large, primarily Caucasian, multi-
tween cases and controls. Familial clustering of nephrop- generation families with multiple T2DM-affected indi-
athy in T1DM also has been observed in the Diabetes viduals encompassing a total of 1269 subjects including
Control and Complications Trial (DCCT) [4]. 630 with T2DM and 639 subjects without diabetes who
Familial clustering of renal disease has been described had renal function measured as the urinary albumin-to-
in T2DM-affected Pima Indians [5], multiple studies of creatinine ratio (ACR) [14]. ACR was mathematically
T2DM-affected African Americans [6], and T2DM- modeled as a continuous trait with the inclusion of age,
affected Caucasians [7, 8]. While not as extensively docu- sex, and duration of diabetes as covariates. The pattern
mented, similar evidence exists that non-diabetic ESRD of ACR inheritance was most consistent with a Mendel-
also shows familial aggregation. For example, in the stud- ian model with multifactorial inheritance, that is, ACR
ies of African Americans, family history of ESRD was is determined by a mixture of genes, variable effects,
evaluated with the conclusion that the presence of a close and other lifestyle/environment factors such as diabetes
relative with ESRD gave an African American an eight- and hypertension. ACR heritability (h2) was estimated
fold increased risk of developing ESRD [9]. In Cauca- to be 0.27, that is, 27% of ACR is determined genetically.
sians the increased risk was 2.7-fold. Subsequently, familial Imperatore et al used a comparable measure of renal
clustering of renal disease has been described in T2DM function, protein-to-creatinine ratio, from 2107 Pima In-
families from populations as diverse as south India [10] dians from 715 nuclear families [15]. They similarly con-
and Brazil [11]. Results of three of these familial aggrega- cluded that a major genetic component contributes to
tion studies are summarized in Figure 1. More recently, nephropathy in Pima Indians with diabetes.
Fioretto et al have re-addressed familial clustering in
T1DM families with a study incorporating the results of
THE SEARCH FOR RENAL DISEASE GENESkidney biopsies in addition to more common measures
of renal function such as urinary albumin excretion rate With the wide acceptance that inheritance contributes
[12]. Mesangial fractional volume clustered in T1DM- to renal disease susceptibility, a broad range of efforts
affected siblings (P 0.01). Patterns of glomerular lesions has been initiated to identify the genes contributing to
such as glomerular basement membrane thickening com- susceptibility. Investigators have followed two main ap-
pared to mesangial matrix expansion were observed also. proaches with a variety of study designs in their effort
Results of familial clustering studies have frequently to identify ESRD genes.
included or been complemented by numerous studies
Candidate gene studiesthat have evaluated incidence of complications in differ-
ent racial or ethnic groups [6–8]. The assumption in these In the candidate gene approach that is familiar to
studies is that different racial and ethnic groups have many investigators, specific genes are selected for analy-
sis based on a function that could be closely related tolived and evolved in different environments with differ-
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Table 1. Genes that have shown evidence of association to renal a powerful vasodilator. One can envision that an alter-
disease in candidate gene studies ation in kallikrein activity, either by mutation or altered
Gene Population levels of expression could lead to local constriction of
blood vessels and potentially contribute to ESRD. TheACE DM1, DM2 nephropathy
Aldose reductase DM1 nephropathy two genes that we have evaluated in the greatest detail
Angiotensinogen DM1 nephropathy are the plasma and tissue kallikrein genes. Studies withAPOE DM1 nephropathy
the plasma kallikrein gene, KLKB1, illustrate a numberBradykinin receptors ESRD
IL1RN DM1, DM2 nephropathy of issues faced in candidate gene analysis.
KLKB1 non-DM renal disease These analyses were initiated with studies evaluatingKLK1 promoter non-DM renal disease
KLKB1 in ESRD in genetic studies. Evidence of associa-NHE5 non-DM renal disease
eNOS DM1 nephropathy tion of KLKB1 with ESRD was observed in African
iNOS non-DM renal disease American families with multiple cases of non-diabetic
ESRD [16]. These studies were then extended to a de-
tailed analysis of the KLKB1 gene searching for DNA
sequence variants or alleles of KLKB1 that might con-
renal disease or through direct empirical evidence that tribute to ESRD [17]. Twelve allelic variants were identi-
the gene product, that is, protein, is associated with renal fied in the 5 proximal promoter and seven exons. Of
pathology. Examples of such genes are cytokines, growth note was a common polymorphism (30% of the popula-
factors, and nitric oxide synthases. Most frequently these tion), at position 521 of KLKB1 cDNA that leads to the
types of studies are carried out in case-control popula- replacement of asparagine with a serine, a seemingly a
tions, comparing allele frequencies in renal disease pa- dramatic change, at position 124 in the substrate binding
tients with allele frequencies in individuals without renal domain A2 (one of four substrate binding domains) of
disease. the protein. In addition, an A716C polymorphism in exon
At this time the candidate gene approach has been 7 resulting in the amino acid change H189P in the sub-
used most widely in genetic studies, with over 100 articles strate binding domain A3 was observed in five patients
belonging to three ESRD families. Another polymor-appearing since 1999 with an analysis of candidate genes
phism in the coding sequence was a C699A shift thatand renal disease. Table 1 lists some of the genes that
caused an amino acid change H183Q. This allele washave been tested and found to have evidence for associa-
observed in eight cases from six ESRD families, but wastion with renal disease. The great challenge of candidate
not found in any control DNAs from control subjects.gene studies is to assess the relative importance of the
The pedigree of a particularly interesting family is shownmany reports. The candidate gene analysis method is
in Figure 2. In this family there are four children withvery sensitive, but also limited by a number of features.
diabetes (three with Type 2 diabetes, DM2, and one withResults from such studies have been notoriously difficult
Type 1 diabetes, DM1) and two children with chronicto independently replicate. If such studies are indeed
renal failure (CRF) or ESRD. Two different uncommonreflecting true associations, one can envision that minor
SNPs are segregating in this family: H183Q and K229E.genetic components may differ significantly in their fre-
Interestingly, the H183Q allele is found in both of thequency from one population to another and even within
renal disease affected siblings and the K229E allele inpopulations from different locales. In addition, popula-
the two diabetes affected, but renal disease unaffectedtions of both cases and controls in different studies are
individuals.frequently ascertained by different criteria, and the re-
Individually or combined, the allelic variants observedsults of genotyping are often interpreted using different
are not statistically associated with ESRD, but in severalstatistical analysis approaches. These possibilities, in com-
cases, for example, H183Q, the small number of people
bination with the fact that many published candidate in the population carrying these alleles limits our ability
gene association analyses are probably underpowered, to statistically test for significant association with ESRD.
increases the likelihood that type 1 error will continually As a consequence, to determine the impact of these
surface as evidence for association. various coding changes, the individual genetic variants
At Wake Forest we have taken a number of ap- will need to be expressed and the proteins assayed for
proaches for evaluating the genetics of renal disease in- functional activity. Importantly though, we may have
cluding studies in families and case:control populations, identified genetic alleles that have a substantial impact
and with genome screens and focused analysis of candi- on renal disease susceptibility, albeit in a small number
date genes. One area on which we have focused is the of people.
evaluation of kallikrein genes. Kallikreins are a class of
Genome screen analysisserine proteases with high substrate specificity. The key
feature of kallikreins relative to renal disease is that The genome screen approach is more difficult, time
consuming, and expensive than candidate gene analysis,these enzymes cleave kininogen to release bradykinin,
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the LOD score they saw on chromosome 7 was 2.7 or
odds of approximately 500:1 that this part of the genome
is linked, that is, co-inherited, with nephropathy in these
Pima Indian families. If this part of chromosome 7 is
inherited more commonly than expected in families with
renal disease, this suggests that a renal disease gene is
located in this part of the genome. They found less strong
evidence for linkage in several other places on the ge-
nome: chromosomes 3, 9, and 20.
At the recent World Congress of Nephrology ASN/ISN
meeting, Vardarli et al reported the results of a genome
scan of 18 Turkish kindreds with multiple diabetic ne-
phropathy-affected individuals (abstract; J Am Soc Nephrol
12:160A, 2001). These unusual families have multiple
cousin-cousin marriages and consequently a significant
inbreeding component. Using an autosomal dominant
model, a strong linkage peak was observed on chromo-
some 18 with a LOD score of 6.6 between genetic mark-
ers D18S43 and D18S50, providing strong evidence for
the existence of a novel renal disease gene. EvaluationFig. 2. Inheritance of KLKB1 allelic variants in an African American
of the loci in the Pima Indian dataset also showed evi-family with multiple of cases of diabetes and renal disease. Abbrevia-
tions are: DM2, Type 2 diabetes mellitus; DM1, Type 1 diabetes mellitus; dence of confirmation (P  0.013 to 0.006), although this
CRF, chronic renal failure; ESRD, end-stage renal disease. region was not linked in the original Pima genome screen.
We are currently analyzing the results of a genome
screen carried out in our laboratories at Wake Forest
University School of Medicine. While not complete,but has the advantage of being able to locate new, as
yet undiscovered, genes. Importantly, the genome screen there are some interesting results to date. Our strongest
evidence for linkage is a LOD score of 3.4 (2500:1) onapproach is not limited to our current knowledge of
renal disease. The genome screen methodology gives a human chromosome 10q in our complete set of ESRD
families that include families with both diabetes associ-comprehensive map of inheritance of all parts of the
human genome in families expressing a specific trait, for ated ESRD and ESRD families without diabetes (ab-
stract; Freedman et al, J Am Soc Nephrol 12:71A, 2001).example, of ESRD.
In a genome screen approximately 400 genetic mark- There is a lesser peak at another location on chromo-
some 10p. There is another peak of 2.35 (220:1 odds ofers that identify evenly spaced locations along each of
the human chromosomes are genotyped in families with linkage) on chromosome 7p that is only seen in diabetes
families, but is at a different location than the peakmultiple cases of ESRD or other forms of renal disease.
What this results in is a dataset that follows the inheri- observed by Imperatore et al [18]. We have looked at
the chromosome 10 data in greater detail by evaluatingtance of every part of every chromosome in each individ-
ual in the study. The idea then is to try to determine by linkage in diabetes and non-diabetic families alone, and
then by analyzing the data by evaluating linkage basedstatistical analysis which parts of which chromosome are
being inherited with renal disease. This is performed by on age of ESRD onset. Interestingly, the 10q peak is
contributed to equally by diabetic and non-diabetic fami-statistical calculations called linkage analysis.
The first genome screen looking for nephropathy lies and early and late onset families. In contrast, the
10p peak is due solely to evidence of linkage in earlygenes was published by the Phoenix group working with
the Pima Indians, where they followed Type 2 diabetes onset, non-diabetic families, and the 7p peak is seen only
with the diabetes affected families.associated nephropathy and also another microvascular
disease, retinopathy [18]. They did this study in 98 sibling Our results, and those of our colleagues, suggest that
the genetic origins of renal disease are heterogeneous:pairs in which each sibling had T2DM and renal failure.
After analyzing their data they saw strongest evidence different genes on different chromosomes may contrib-
ute to susceptibility in different populations and may befor linkage on the long arm of chromosome 7. Results
of these kinds of analyses are expressed statistically as specific for certain disease etiologies or general to all
origins of renal disease. It is important to emphasize thatLOD scores. LOD stands for log of the odds, in this case
to the base 10. Thus, the LOD score is an expression of researchers are just in the early stages of these types of
comprehensive genetic analyses. Results so far are simi-the probability that this part of the genome or chromo-
some is being inherited with renal disease. In this case lar in content to studies of other complex diseases such
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